GE HealthCare Technologies (GEHC) Liabilities and Shareholders Equity (2022 - 2026)

GE HealthCare Technologies (GEHC) posted Liabilities and Shareholders Equity of $37.1 billion for Q1 2026, up 0.59% on a QoQ basis from $36.9 billion in Q4 2025, and up 95092.31% year-over-year from N/an in Q1 2025.

GE HealthCare Technologies (GEHC) Liabilities and Shareholders Equity (2022 - 2026) Analysis & Trends

GE HealthCare Technologies' Liabilities and Shareholders Equity history runs 5 years deep, the most recent figure standing at $37.1 billion for Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 95092.31% year-over-year to $37.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $145.7 billion (up 47.37% YoY) and the FY2025 annual result came in at $36.9 billion, up 11.54% from the prior year.
  • Liabilities and Shareholders Equity was $37.1 billion for Q1 2026 at GE HealthCare Technologies, up from $36.9 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $37.1 billion in Q1 2026 and bottomed at $39.0 million in Q1 2025.
  • A 5-year average of $31.0 billion and a median of $32.5 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2025 — Liabilities and Shareholders Equity sank 99.88% — and 2026, when it surged 95092.31%.
  • GE HealthCare Technologies' Liabilities and Shareholders Equity stood at $27.5 billion in 2022, then grew by 17.85% to $32.5 billion in 2023, then grew by 1.96% to $33.1 billion in 2024, then advanced by 11.54% to $36.9 billion in 2025, then grew by 0.59% to $37.1 billion in 2026.
  • Business Quant data shows GEHC's Liabilities and Shareholders Equity at $37.1 billion in Q1 2026, $36.9 billion in Q4 2025, and $36.1 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 110.43 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 46.29 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 6.63 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 31.92 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 37.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 10.46 Bn
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn 10.74 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 37.13 Bn
Dec 31, 2025 36.91 Bn
Sep 30, 2025 36.13 Bn
Jun 30, 2025 35.50 Bn
Mar 31, 2025 39.00 Mn
Dec 31, 2024 33.09 Bn
Sep 30, 2024 33.86 Bn
Jun 30, 2024 31.85 Bn
Mar 31, 2024 32.21 Bn
Dec 31, 2023 32.45 Bn
Sep 30, 2023 32.38 Bn
Jun 30, 2023 32.31 Bn
Mar 31, 2023 32.64 Bn
Dec 31, 2022 27.54 Bn